PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'ImmunityBio, Inc., Culver City, CA, United States.\', \'IosBio, Burgess Hill, United Kingdom.\', \'Battelle Biomedical Research Center, Columbus, OH, United States.\', \'NantKwest, Inc., Culver City, CA, United States.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fimmu.2021.729837
?:doi
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 34603305
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Dual-Antigen COVID-19 Vaccine Subcutaneous Prime Delivery With Oral Boosts Protects NHP Against SARS-CoV-2 Challenge.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all